Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Seaport Therapeutics, Inc. - Common Stock (NQ:SPTX)

22.96 -1.74 (-7.04%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 158,970
Open 24.56
Bid (Size) 22.52 (400)
Ask (Size) 29.50 (100)
Prev. Close 24.70
Today's Range 22.63 - 24.95
52wk Range 14.85 - 28.38
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Seaport Therapeutics to Participate in September Investor Conferences
From Seaport Therapeutics, Inc.
Via Business Wire
News headline image
PureTech Founded Entity Seaport Therapeutics Reports Positive Topline Results from Phase 1 Driving Simulation Trial of GlyphAllo™ in Healthy Volunteers
From PureTech Health plc
Via Business Wire

Performance

YTD
+15.7%
+15.7%
1 Month
-5.9%
-5.9%
3 Month
+27.8%
+27.8%
6 Month
+15.7%
+15.7%
1 Year
+15.7%
+15.7%

More News

Read More
News headline image
Seaport Therapeutics Reports Positive Topline Results from Phase 1 Driving Simulation Trial of GlyphAllo™ in Healthy Volunteers
From Seaport Therapeutics, Inc.
Via Business Wire
News headline image
Seaport Therapeutics to Present at Citi’s 2026 Biopharma Back to School Conference and Participate in 21st Annual Wells Fargo Healthcare Conference
From Seaport Therapeutics, Inc.
Via Business Wire
News headline image
Seaport Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
From Seaport Therapeutics, Inc.
Via Business Wire
News headline image
PureTech Founded Entity Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers
From PureTech Health plc
Via Business Wire
News headline image
Seaport Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
From Seaport Therapeutics, Inc.
Via Business Wire
News headline image
Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers
From Seaport Therapeutics, Inc.
Via Business Wire
News headline image
Seaport Therapeutics to Participate in Two Upcoming Investor Conferences
From Seaport Therapeutics, Inc.
Via Business Wire

Frequently Asked Questions

Is Seaport Therapeutics, Inc. - Common Stock publicly traded?
Yes, Seaport Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Seaport Therapeutics, Inc. - Common Stock trade on?
Seaport Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Seaport Therapeutics, Inc. - Common Stock?
The ticker symbol for Seaport Therapeutics, Inc. - Common Stock is SPTX on the Nasdaq Stock Market
What is the current price of Seaport Therapeutics, Inc. - Common Stock?
The current price of Seaport Therapeutics, Inc. - Common Stock is 22.96
When was Seaport Therapeutics, Inc. - Common Stock last traded?
The last trade of Seaport Therapeutics, Inc. - Common Stock was at 09/15/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.